Skip to main content

Co-Diagnostics Receives PCR Technology from DNA Logix

NEW YORK (GenomeWeb News) – Co-Diagnostics said recently that certain real-time PCR technology has been transferred to the company from DNA Logix.

DNA Logix transferred four patents and applications pursuant to a purchase agreement between the two firms. Under the terms of the agreement, Co-Diagnostics, based in Salt Lake City, exercised its option to purchase the technology related to real-time PCR diagnostics testing.

The patents and applications that were transferred are titled, "Methods of Preventing Non-Specific Reactions of Nucleotide Sequences;" "Rapid Oligo Probes;" "Detection Primers for Nucleic Acid Extensions or Amplification Reactions;" and "Primers for Nucleic Acid Extension or Amplification Reactions."

In a statement, Co-Diagnostics President Dwight Egan said that "the patents transferred contain cutting-edge technology in the molecular diagnostic testing industry and represent a breakthrough that will enable testing to be performed much less expensively than is standard in the industry at the present time."

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.